Bioscience Animal Health PCL
SET:BIS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Bioscience Animal Health PCL
Long-Term Debt
Bioscience Animal Health PCL
Long-Term Debt Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Long-Term Debt | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
B
|
Bioscience Animal Health PCL
SET:BIS
|
Long-Term Debt
฿3.9m
|
CAGR 3-Years
0%
|
CAGR 5-Years
-38%
|
CAGR 10-Years
N/A
|
|
|
W
|
Winnergy Medical PCL
SET:WINMED
|
Long-Term Debt
฿150.4m
|
CAGR 3-Years
33%
|
CAGR 5-Years
24%
|
CAGR 10-Years
N/A
|
|
|
B
|
Business Alignment PCL
SET:BIZ
|
Long-Term Debt
฿134.3m
|
CAGR 3-Years
-17%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
N/A
|
|
|
T
|
Techno Medical PCL
SET:TM
|
Long-Term Debt
฿87.1m
|
CAGR 3-Years
-1%
|
CAGR 5-Years
122%
|
CAGR 10-Years
N/A
|
|
|
E
|
E for L Aim PCL
SET:EFORL
|
Long-Term Debt
฿138.5m
|
CAGR 3-Years
-25%
|
CAGR 5-Years
11%
|
CAGR 10-Years
-17%
|
|
|
S
|
SEI Medical PCL
SET:SEI
|
Long-Term Debt
฿17.7m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Bioscience Animal Health PCL
Glance View
Bioscience Animal Health Public Co. Ltd. engages in manufacturing, importing, and distribution of medical supplies, tools, equipment, and products for livestock and pets. The company is headquartered in Pak Kret, Nonthaburi. The company went IPO on 2022-05-05. The firm is an importer and distributor of medical supplies, tools, equipment and products for livestock and pets. The company focuses on selecting products by specialist veterinarians to improve animal health. The firm's products include antibiotic, additive, BiSMiX B-Series, BiSMiX SD Series, injection, mold inhibitor, water-soluble products, vaccine and certificate bioscience. The antibiotic includes Omnicide FG II 1 Lit, Green Bioxide 20Liter, Salinopharm, Cevazuril, and Porcillin. Its additive pHorce, orego-stim-powder, Optiphos, Moldgard, Mastercube and Lianol solapro. The injection consists of Zuprevo, Nuflor, Ceva and Enzaprost. The water-soluble products consist of Tilmosin AC, Surmox col and Coliscour. The firm's subsidiaries include Feed and Ingredients Technological Hub Co., Ltd., Special Ingredient Services Co., Ltd., and others.
See Also
What is Bioscience Animal Health PCL's Long-Term Debt?
Long-Term Debt
3.9m
THB
Based on the financial report for Dec 31, 2025, Bioscience Animal Health PCL's Long-Term Debt amounts to 3.9m THB.
What is Bioscience Animal Health PCL's Long-Term Debt growth rate?
Long-Term Debt CAGR 5Y
-38%
Over the last year, the Long-Term Debt growth was -45%.
